{
  "id": "5e2a080caa19d7443100000a",
  "type": "factoid",
  "question": "Through which molecular pathway does LB-100 reduce hepatic steatosis?",
  "ideal_answer": "PP2A inhibition by LB100 significantly ameliorates hepatic steatosis by regulating hepatic lipogenesis and fatty acid oxidation via the AMPK/Sirt1 pathway.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/31832001"
  ],
  "snippets": [
    {
      "text": " PP2A inhibition by LB100 significantly ameliorates hepatic steatosis by regulating hepatic lipogenesis and fatty acid oxidation via the AMPK/Sirt1 pathway. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31832001",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "AMPK/Sirt1 pathway"
}